These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16863588)

  • 61. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN; Perkins JD; Carithers RL
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.
    Pandey D; Lee KH; Wai CT; Wagholikar G; Tan KC
    Ann Surg Oncol; 2007 Oct; 14(10):2817-23. PubMed ID: 17690940
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.
    Kondo K; Chijiiwa K; Nagano M; Hiyoshi M; Kai M; Maehara N; Ohuchida J; Nakao H; Ohkuwa Y
    Hepatogastroenterology; 2007; 54(77):1534-8. PubMed ID: 17708292
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma.
    Elba S; Giannuzzi V; Misciagna G; Manghisi OG
    Ital J Gastroenterol; 1994 Mar; 26(2):66-8. PubMed ID: 8032079
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial.
    Perrone F; Gallo C; Daniele B; Gaeta GB; Izzo F; Capuano G; Adinolfi LE; Mazzanti R; Farinati F; Elba S; Piai G; Calandra M; Stanzione M; Mattera D; Aiello A; De Sio I; Castiglione F; Russo M; Persico M; Felder M; Manghisi OG; De Maio E; Di Maio M; Pignata S;
    Curr Pharm Des; 2002; 8(11):1013-9. PubMed ID: 11945148
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Regression of hepatocellular carcinoma under Tamoxifen: report of one case and review of the literature].
    Macaigne G; Auriault ML; Boivin JF; Cheaib S; Chayette C; Deplus R
    Gastroenterol Clin Biol; 2002 Dec; 26(12):1165-7. PubMed ID: 12520204
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tamoxifen does not improve overall survival in people with advanced-stage hepatocellular carcinoma.
    Chow PK
    Cancer Treat Rev; 2005 Oct; 31(6):491-5. PubMed ID: 16214294
    [No Abstract]   [Full Text] [Related]  

  • 69. Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial.
    Dollinger MM; Lautenschlaeger C; Lesske J; Tannapfel A; Wagner AD; Schoppmeyer K; Nehls O; Welker MW; Wiest R; Fleig WE;
    BMC Cancer; 2010 Aug; 10():457. PubMed ID: 20735834
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Randomized trial of elliptinium acetate and tamoxifen in the treatment of inoperable hepatocellular carcinoma].
    Jouanolle H; Delamaire D; Deugnier Y; Lhéry D; Simon M; Brissot P; Bourel M
    Gastroenterol Clin Biol; 1986 Feb; 10(2):185-7. PubMed ID: 3009255
    [No Abstract]   [Full Text] [Related]  

  • 71. CLIP score as a prognostic indicator for hepatocellular carcinoma: experience with patients in the Middle East.
    Siddique I; El-Naga HA; Memon A; Thalib L; Hasan F; Al-Nakib B
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):675-80. PubMed ID: 15201581
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma.
    Riestra S; Rodriguez M; Delgado M; Suárez A; González N; de la Mata M; Diaz G; Miño-Fugarolas G; Rodrigo L
    J Clin Gastroenterol; 1998 Apr; 26(3):200-3. PubMed ID: 9600369
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effects of a tamoxifen-norethisterone combination in 16 patients with hepatocellular carcinoma].
    Trinchet JC; Roudil F; Vaysse J; Beaugrand M
    Gastroenterol Clin Biol; 1985 May; 9(5):455-6. PubMed ID: 2989070
    [No Abstract]   [Full Text] [Related]  

  • 74. [Treatment of hepatocellular carcinoma with tamoxifen].
    Paliard P; Clément G; Saez S; Chabal J; Partensky C
    Gastroenterol Clin Biol; 1984; 8(8-9):680-1. PubMed ID: 6092188
    [No Abstract]   [Full Text] [Related]  

  • 75. Response of negative estrogen-receptor hepatocarcinoma to tamoxifen, and survival of non-resectable patients.
    García-Leiva J; Gamboa-Domínguez A; Ceron-Lizarraga T; Morales-Espinosa D; Meza-Junco J; Arrieta O
    Ann Hepatol; 2006; 5(4):263-7. PubMed ID: 17151578
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A phase II trial of tamoxifen in hepatocellular carcinoma.
    Engstrom PF; Levin B; Moertel CG; Schutt A
    Cancer; 1990 Jun; 65(12):2641-3. PubMed ID: 2160313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Controlled clinical trial of doxorubicin and tamoxifen versus tamoxifen monotherapy in hepatocellular carcinoma.
    Schachschal G; Lochs H; Plauth M
    Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):281-4. PubMed ID: 10750647
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma.
    Martínez Cerezo FJ; Tomás A; Donoso L; Enríquez J; Guarner C; Balanzó J; Martínez Nogueras A; Vilardell F
    J Hepatol; 1994 Jun; 20(6):702-6. PubMed ID: 7930468
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients.
    Castells A; Bruix J; Brú C; Ayuso C; Roca M; Boix L; Vilana R; Rodés J
    Gastroenterology; 1995 Sep; 109(3):917-22. PubMed ID: 7657122
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Treatment of hepatocellular carcinoma with tamoxifen].
    Raoul JL
    Gastroenterol Clin Biol; 1996 Mar; 20(2):221-2. PubMed ID: 8761695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.